Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Discover the key items to track in a monthly budget, from income to variable expenses, to ensure you meet your financial targets.
17,687 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A Northeast Ohio real estate team built on disciplined systems rises to No. 1 in Ohio among medium teams for 2025, wi...
Bitcoin’s bear market struggle is driving layoffs and automation in crypto firms even as banks and fintechs chase big...
Amazon is exploring a new growth lane: selling its Trainium AI chips to external customers. This article breaks down ...
If you’re worried about stock market volatility, a proven dividend stock can be your anchor. This guide explains why ...
Savara investors should stay focused on how insider moves and regulatory timelines interact with a growing biotech st...
As token prices falter, traders are eyeing crypto-linked equities as the potential catalyst for the next crypto recov...
What would it take for Micron Technology stock to run from here to a life-changing level in a year? This article lays...
Two fast-casual leaders headline the 2026 investor debate: a Mediterranean newcomer with fast expansion and a Mexican...
When a CEO discloses a sale of 41,600 shares, investors pay attention. This article unpacks the implications, the mec...
The dutch bros stock gained 23.8% last month, powering higher on a mix of macro relief and company-specific growth si...
Investors are buzzing about United States Antimony as shipments update boosts sentiment. This article breaks down the...